AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide.
It operates through two segments, Food Safety and Animal Safety.
The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells.
This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines.
The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market.
This segment offers various products for researchers to detect biologically active substances.
Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications.
In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses.
Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Country | United States |
IPO Date | Aug 23, 1989 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 2,917 |
CEO | John Edward Adent |
Contact Details
Address: 620 Lesher Place Lansing, Michigan United States | |
Website | https://www.neogen.com |
Stock Details
Ticker Symbol | NEOG |
Exchange | NASDAQ |
Fiscal Year | June - May |
Reporting Currency | USD |
CIK Code | 0000711377 |
CUSIP Number | 640491106 |
ISIN Number | US6404911066 |
Employer ID | 38-2367843 |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
John Edward Adent | President, Chief Executive Officer & Director |
David H. Naemura | Chief Financial Officer |
Douglas E. Jones | Chief Operating Officer & Vice President |
Amy M. Rocklin Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Bill Waelke | Head of Investor Relations |
Dr. Robert S. Donofrio Ph.D. | Vice President & Chief Scientific Officer |
John Moylan | Vice President, Corporate Controller & Chief Accounting Officer |
Julie A. Mann | Vice President & Chief Human Resources Officer |
Sarah Demey | Administrative Manager |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 17, 2024 | 8-K/A | [Amend] Current Report |
Dec 04, 2024 | 8-K | Current Report |
Dec 02, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 05, 2024 | 4 | Filing |
Nov 04, 2024 | 3 | Filing |
Nov 04, 2024 | SCHEDULE 13G | Filing |
Oct 29, 2024 | 4 | Filing |
Oct 29, 2024 | 4 | Filing |